Scientific Coordination

Coordinator - Inserm

Rodolphe Thiébaut
INSERM,
USMR
146, rue Léo Saignat
33076 Bordeaux
France

Anton Ottavi
INSERM,
USMR
146, rue Léo Saignat
33076 Bordeaux
France
Email : Anton.Ottavi@isped.u-bordeaux2.fr

Project Leader – Janssen

Macaya Douoguih
4-6 Archimedesweg, Leiden,
2333 CN,
Netherlands

Ellen Hubin
Contractor of Janssen Pharmaceutica NV
Beerse 1, Building 103, 1st floor, office 108
Turnhoutseweg 30 | Beerse, Antwerp 2340 (BE)
Email: ehubin1@its.jnj.com

Project Management Team – Inserm Transfert

Patricia Joseph-Mathieu
INSERM TRANSFERT
Paris Biopark
7, rue Watt
75013 Paris
France
Email: patricia.joseph-mathieu@inserm-transfert.fr

Sinéad Quigley
INSERM TRANSFERT
CHU du Vinatier,
Bât 452B, 95, Bd Pinel
69500 Bron
France
Email: sinead.quigley@inserm-transfert.fr

News

  • 17 January 2018

    Clinical Trial Training - Bobo Dioulasso, BURKINA FASO, 23-26 January, 2018

  • 02 January 2018

    The 4th edition of our EBOVAC2 newlsetter was released on the 21st of December 2017.

  • 27 October 2017

    The 3rd EBOVAC2 Newsletter is now available here. Our October 2017 issue includes an interview with Dr Houreratou Barry, PI of the Centre Muraz site.

  • 12 September 2017

    The 3rd EBOVAC1/2 Annual meeting will be held in Amsteram, the Netherlands 8-10 January 2018. Participants include consortium members and representatives of sites where the project clinical trials are being carried out.

  • 27 June 2017

    The 2nd EBOVAC2 newsletter June 2017 is now available here!

  • 15 May 2017

    Based on final Phase 1 data published in JAMA: The Journal of the American Medical Association, the prime-boost Ebola vaccine regimen induced an antibody response that persisted in 100 percent of healthy volunteers to at least 1 year following vaccination. The results are from the EBOVAC1 study EBL1001 conducted by the Oxford Vaccine Group in the UK.

More news
  • Ebola: background

    What is Ebola?

  • Phase 2 trials

    Find out more about EBOVAC2 trials

  • Work programme

    EBOVAC2 is organised into 6 workpackages (WP)

  • Ebola+ programme

    Contributes to efforts to tackle a wide range of challenges in Ebola research